Pre ve Probiyotikler

Öz

@font face { font family: Times ; }p MsoNormal li MsoNormal div MsoNormal { margin: 0cm 0cm 0 0001pt; font size: 12pt; font family: Times New Roman ; }div Section1 { page: Section1; }

Anahtar Kelimeler

• Prebiyotikler, probiyotikler, çocuklar, ergenler, sağlık yararları

Prebiotics and probiotics

Abstract

@font face { font family: Times ; }p MsoNormal li MsoNormal div MsoNormal { margin: 0cm 0cm 0 0001pt; font size: 12pt; font family: Times New Roman ; }div Section1 { page: Section1; }

Keywords

• -

References

1. Gupta V, Garg R. Probiotics. Ind J Med Microb 2009; 27: 202-9. (Abstract) / (Full Text)
2. Wallace B. Clinical use of probiotics in the pediatric population. Nutr Clin Pract 2009; 24: 50-9. (Abstract) / (Full Text) / (PDF)
3. Michail S, Abernathy F. Lactobacillus plantarum inhibits the intestinal epithelial migration of neutrophils induced by enteropathic Escherichia coli. J Pediatr Gastroenterol Nutr 2003; 36: 385-91. (Abstract) / (Full Text) / (PDF)
4. Dahan S, Dalmasso G, Imbert V, Peyron JF, Rampal P, Czerucka D. Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli induces signaling pathways in T84 cells. Infect Immun 2003; 71: 766-73. (Abstract) / (Full Text) / (PDF)
5. Heller F, Duchmann R. Intestinal flora and mucosal immune responses. Int J Med Microbiol 2003; 293: 77-86. (Abstract)
6. McCarthy J, O’Mahony L, O’Callaghan L, et al. Double blind placebo conrolled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003;52:975-80. (Abstract) / (Full Text) / (PDF)
7. Vanderhoof JA, Young RJ. Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr 1998; 27: 323-32. (Abstract) / (Full Text) / (PDF)
8. Szajewska H, Mrukowics JZ. Use of probiotics in children with acute diarrhea. Paediatr Drugs 2005; 7: 111-2. (Abstract)

9. Vanderhoof J, Whitney D, Antonson DL, Hanner TL, Lupo JP, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999; 135: 564-8. (Abstract) / (Full Text) / (PDF)
10. Miele E, Pascarella F, Giannetti E, Quaglietta L, Baldassano RN, Staiano A. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 2009;104:437-43. (Abstract)
11. Bausserman M, Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blinded randomized control trial. J Pediatr 2005;147:197-201. (Abstract) / (Full Text) / (PDF)
12. Bekkali NLH, Bongers MEJ, Van den Berg MM, Liem O, Benninga MA. The role of probiotics mixture in the treatment of childhood constipation: a pilot study. Nutr J 2007; 6: 17. (Abstract) / (Full Text) / (PDF)
13. Alfaleh K. Probiotics for prevention of necrotizing enterocolitis in preterms infants. Cochrane Database Syst Rev 2008; 1: CD005496. (Abstract) / (Full Text) / (PDF)
14. Sentengo TA, Cohran V, Korff S, Sullivan C, Lyer K, Sheng X. Intestinal permeability and effects of Lactobacillus rhamnosis therapy in children with short bowel syndrome. J Pediatr Gastroenterol Nutr 2008; 46: 41-7. (Abstract) / (Full Text) / (PDF)
15. Goldman CG, Barrado DA, Balcarce N et al. Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children. Nutrition 2006; 22: 984-8. (Abstract) / (Full Text) / (PDF)
16. Yao TC, Chang CJ, Hsu YH, Huang JL. Probiotics for allergic diseases: realities and myths. Pediatr Allergy Immunol. 2010; 21: 900-19. (Abstract) / (Full Text) / (PDF)
17. Reid G. The potential role of probiotics in pediatric urology. J Urol 2002; 168: 1512-7. (Abstract)
18. Larkin TA, Astheimer LB, Price WE. Dietary combination of soy with a probiotic or prebiotic food significantly reduces total and LDL cholesterol in mildly hypercholesterolaemic subjects. Eur J Clin Nutr 2009; 63: 238-45. (Full Text)
19. Gismondo MR, Drago L, Lombardi A. Review of probiotics available to modify gastrointestinal flora. Int J Antimicrob Agents 1999; 12: 287-92. (Abstract) / (Full Text) / (PDF)
20. Guarino A, Canani RB, Spagnuolo MI, Albano F, Di Benedetto L. Oral bacterial therapy reduces the duration of symptom and viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr 1997; 25: 516-9. (Abstract) / (Full Text)
21. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhea. Cochrane Database Syst Rev 2003; 4: CD003048. (Full Text)
22. Canani RB, Cirillo P, Terrin G, et al. Probiotics for treatment of acute diarrhea in children: randomized clinical trial of five different preparations. BMJ 2007; 335: 340. (Abstract) / (Full Text) / (PDF)
23. Villaruel G, Rubio DM, Lopez F, et al. Saccharomyces boulardii in acute childhood diarrhea: a randomized, placebo-controlled study. Acta Paediatr 2007; 96: 538-41. (Abstract) / (Full Text) / (PDF)
24. Saaverda JM. Probiotics plus antibiotics: regulating our bacterial environment. J Pediatr 1999; 135: 535-7. (Abstract) / (Full Text) / (PDF)
25. McFarland LV. A review of the evidence of health claims for biotherapeutic agents. Microbiol Ecol Health Dis 2000; 12: 65-76. (Abstract) / (PDF)
26. McFarland LV. Normal flora: diversity and functions. Microbiol Ecol Health Dis 2000; 12: 193-207. (Abstract)
27. Wistrom J, Norrby SR, Myhre EB, et al. Frequency of antibiotic- associated diarrhea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 2001; 47: 43-50. (Abstract) / (Full Text) / (PDF)
28. Turck D, Bernet JP, Marx J, et al. Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population. J Pediatr Gastroenterol Nutr 2003; 37: 22-6. (Abstract)
29. Gogate A, De A, Nanivadekar R, Mathur M, Saraswathi K, Jog A, Kulkarni MV. Diagnostic role of stool culture and toxin detection in antibiotic associated diarrhea due to Clostridium difficile in children. Ind J Med Res 2005; 122: 518-24. (PDF)
30. Johnston BC, Supina AL, Ospina M, Vohra S. Probiotics fort he prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2007; 1: CD004827. (Full Text) / (PDF)
31. Dong L, Dingguo L, Xiaoxing X, Hanming L. An epidemiologic study of irritable bowel syndrome in adolescents and children in China: a school-based study. Pediatrics 2005; 116: e393-6. (Abstract) / (Full Text) / (PDF)
32. McFarland LV, Dublin S. Meta-analysis of probiotics fort he treatment of irritable bowel syndrome. World J Gastroenterol 2008; 14: 2650-61. (Abstract) / (Full Text) / (PDF)
33. Gawronska A, Dziechciarz P, Horvath A, Szajewska H. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther 2007; 25: 177-84. (Abstract) / (Full Text) / (PDF)
34. Chmielewska A. Systematic review of randomised controlled tri- als: probiotics for functional constipation World J Gastroenterol 2010; 16: 69-75. (Abstract) / (Full Text) / (PDF)
35. Ghosh S, Van Heel D, Playford RJ. Probiotics in inflammatory bowel disease: is it all gut flora modulation? Gut 2004; 53: 620-2. (Full Text) / (PDF)
36. Heuschkel R, Afzal N, Wuerth A, et al. Complementary medicine use in children and young adults with inflammtory bowel disease. Am J Gastroenterol 2002; 97: 382-8. (Full Text)
37. Bousvaros A, Guandalini S, Baldassano R, et al. A randomized double-blind trial of Lactobacillus GG versus placebo in addition to standart maintenance therapy for children with Crohn’s disease. Inflamm Bowel Dis 2005; 11: 833-9. (Abstract)
38. Kruis W, Fric P, Pokrotnieks J, et al. Maintaining remission of ulcerative colitis with the probiotic E. Coli Nissle 1917 is as effective as with standart mesalazine. Gut 2004; 53: 1617-23. (Abstract) / (Full Text) / (PDF)
39. Henker J, Müller S, Laas MW, Schreiner A, Schulze J. Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open label pilot study. Z Gastroenterol 2008; 46: 874-5. (Full Text) / (PDF)
40. Tong JL, Ran ZH, Shen J, Zhang CX, Xiao SD. Meta-analysis: the effect of supplementation with probiotics on eradication rates and side effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2007; 25: 155-68. (Abstract) / (Full Text) / (PDF)
41. Sykora J, Valecková K, Amlerová J, et al. Effects of a specially designed fermented milk product containing probiotic lactobacillus casei DN-114 001 and the eradication of H. Pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol 2005; 39: 692-8. (Abstract)
42. Gotteland M, Poliak L, Cruchet S, Brunser O. Effect of regular ingestion of Saccharomyces boulardii plus inulin Lactobacillus acidophilis LB in children colonized by Helicobacter pylori. Acta Paediatr 2005; 94: 1747-51. (Abstract) or
43. Heine RG. Pathophysiology, diagnosis and treatment of food protein induced gastrointestinal diseases. Curr Opin Allergy Clin Immunol 2004; 4: 221-9. (Abstract)
44. Agostoni C, Axelsson I, Goulet O, et al. ESPGHAN Committee on nutrition. Prebiotic oligosaccharides in dietetic products for infants: a commentery by the ESPGHAN Committee on nutrition. J Pediatr Gastroenterol Nutr 2004; 39: 465-73. (Abstract) / (Full Text) / (PDF)
45. Van Odijk J, Kull I, Borres MP, et al. Breastfeeding and allergic disease: a multidisciplinary review of the literature (1966-2001) on the mode of early feding in infancy and its impact on later atopic manifestations. Allergy 2003; 58: 833-43. (Abstract) / (Full Text) / (PDF)
46. Abrahamsson TR, Jakobsson T, Bottcher MF, et al. Probiotics in prevention of IgE associated eczema: a double blind randomized placebo controlled trial. J allergy Clin Immunol 2007; 119: 1174-80. (Abstract) / (Full Text) / (PDF)
47. Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008; 121: 116-21. (Abstract) / (Full Text) / (PDF)
48. Kalliomaki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 1019-21. (Abstract) / (Full Text) / (PDF)
49. Ishida Y, Nakamura F, Kanzato H, et al. Clinical effects of Lactobacillus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study. J Dairy Sci 2005; 88: 527-33. (Abstract) / (Full Text) / (PDF)
50. Morita H, He F, Kawase M, et al. Preliminary human study for possible alteration of serum immunoglobulin E production in perennial allergic rhinitis with fermented milk prepared with Lactobacillus gasseri MC0356. Microbiol Immunol 2006;50:701-6. (Abstract)
51. Nishimura I, Igarashi T, Enomoto T, Dake Y, Okuno Y, Obata A. Clinical efficacy of halophilic lactic acid bacterium Tetragenococcus halophilus Th221 from soy sauce moromi for perennial allergic rhinitis. Allergol Int 2009; 58: 179-85. (Full Text) / (PDF)
52. Xiao JZ, Kondo S, Yanagisawa N, et al. Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo- controlled trial. Clin Exp Allergy 2006; 36: 1425-35. (Abstract) / (Full Text) / (PDF)
53. Kubota A, HE F, Kawase M, et al. Lactobacillus strains stabilize intestinal microbiota in Japanese cedar pollinosis patients. Microbiol Immunol 2009; 53: 198-205. (Abstract)
54. Tamura M, Shikina T, Morihana T, et al. Effects of probiotics on allergic rhinitis induced by Japanese cedar polen: randomized double-blind, placebo-controlled clinical trial. Int Arch Allergy Immunol 2007;143:75-82. (Abstract) / (Full Text) / (PDF)
55. Wang MF, Lin HC, Wang YY, Hsu CH. Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr Allergy Immunol 2004; 15: 152-8. (Abstract) / (Full Text) / (PDF)
56. Peng C, Hsu CH. The efficacy and safety of heat-killed Lactobacillus paracasai for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatr Allergy Immunol 2005; 16: 433-8.
57. Wheeler JG, Shema SJ, Bogle ML, et al. Immune and clinical impact of Lactobacillus acidophilus on asthma. Ann Allergy Asthma Immunol 1997; 79: 229-33. (Abstract) / (PDF)
58. Giovannini M, Agostoni C, Riva E, et al. A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis. Pediatr Res 2007;62:215-20. (Abstract) / (Full Text) / (PDF)
59. Vliagoftis H, Kouranos VD, Betsi GI, Flagas ME. Probiotics fort the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol 2008; 101: 570-9. (Abstract) / (Full Text) / (PDF)
60. Turchet P, Laurenzano M, Auboiron S, Antoine JM. Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects : a randomised, controlled pilot study. J Nutr Health Aging 2003; 7: 75-7. (Abstract)
61. Cobo Sanz JM, Mateos JA, Muñoz Conejo A. Effect of Lactobacillus casei on the incidence of infectious conditions in children. Nutr Hosp 2006;21:547-51. (Abstract)
62. Barrons R, Tassone D. Use of Lactobacillus probiotics for bacterial genitourinary infections in women. Clin Ther 2008; 30: 453-68. (Abstract) / (Full Text)
63. Reid G. Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 2001; 73: 437S-43. (Abstract) / (Full Text) / (PDF)
64. Boyle RJ, Robins-Browne RM, Tang M. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 2006; 83: 1256-64. (Abstract) / (Full Text) / (PDF)
65. Cesaro S, Chinello P, Rossi L, Zanesco L. Saccaromyces cerevisae fungemia in a neutropenic patient treated with Sacchromyces boulardii. Support Care Cancer 2000; 8: 504-5. (Abstract)
66. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005; 115: 178-81. (Abstract) / (Full Text) / (PDF)